LDCT is an effective tool for detecting early-stage lung cancer and reducing mortality, and with the support of the ministry ...

Innovent Biologics (OTCPK:IVBIY) announced that Chinese regulators have approved its second marketing application for lung cancer therapy, Dovbleron, developed with U.S. biotech Nuvation Bio ...

AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova ... KRAS-mutated non-small cell lung cancer (NSCLC), but target KRAS ...

Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...